期刊文献+
共找到887篇文章
< 1 2 45 >
每页显示 20 50 100
Network pharmacology-based exploration of molecular mechanisms underlying therapeutic effects of Jianpi Huatan Quyu recipe on chronic heart failure with spleen Qi deficiency syndrome 被引量:1
1
作者 Si-Qi Li Dong-Yu Min +7 位作者 Jun-Wen Jiang Xiao-Ying Li Xu-Na Yang Wen-Bo Gu Jia-Hui Jiang Li-Hao Chen Han Nan Ze-Yu Chen 《World Journal of Cardiology》 2024年第7期422-435,共14页
BACKGROUND Chronic heart failure is a complex clinical syndrome.The Chinese herbal compound preparation Jianpi Huatan Quyu recipe has been used to treat chronic heart failure;however,the underlying molecular mechanism... BACKGROUND Chronic heart failure is a complex clinical syndrome.The Chinese herbal compound preparation Jianpi Huatan Quyu recipe has been used to treat chronic heart failure;however,the underlying molecular mechanism is still not clear.AIM To identify the effective active ingredients of Jianpi Huatan Quyu recipe and explore its molecular mechanism in the treatment of chronic heart failure.METHODS The effective active ingredients of eight herbs composing Jianpi Huatan Quyu recipe were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform.The target genes of chronic heart failure were searched in the Genecards database.The target proteins of active ingredients were mapped to chronic heart failure target genes to obtain the common drugdisease targets,which were then used to construct a key chemical componenttarget network using Cytoscape 3.7.2 software.The protein-protein interaction network was constructed using the String database.Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed through the Metascape database.Finally,our previously published relevant articles were searched to verify the results obtained via network pharmacology.RESULTS A total of 227 effective active ingredients for Jianpi Huatan Quyu recipe were identified,of which quercetin,kaempferol,7-methoxy-2-methyl isoflavone,formononetin,and isorhamnetin may be key active ingredients and involved in the therapeutic effects of TCM by acting on STAT3,MAPK3,AKT1,JUN,MAPK1,TP53,TNF,HSP90AA1,p65,MAPK8,MAPK14,IL6,EGFR,EDN1,FOS,and other proteins.The pathways identified by KEGG enrichment analysis include pathways in cancer,IL-17 signaling pathway,PI3K-Akt signaling pathway,HIF-1 signaling pathway,calcium signaling pathway,cAMP signaling pathway,NF-kappaB signaling pathway,AMPK signaling pathway,etc.Previous studies on Jianpi Huatan Quyu recipe suggested that this Chinese compound preparation can regulate the TNF-α,IL-6,MAPK,cAMP,and AMPK pathways to affect the mitochondrial structure of myocardial cells,oxidative stress,and energy metabolism,thus achieving the therapeutic effects on chronic heart failure.CONCLUSION The Chinese medicine compound preparation Jianpi Huatan Quyu recipe exerts therapeutic effects on chronic heart failure possibly by influencing the mitochondrial structure of cardiomyocytes,oxidative stress,energy metabolism,and other processes.Future studies are warranted to investigate the role of the IL-17 signaling pathway,PI3K-Akt signaling pathway,HIF-1 signaling pathway,and other pathways in mediating the therapeutic effects of Jianpi Huatan Quyu recipe on chronic heart failure. 展开更多
关键词 Jianpi Huatan quyu recipe Traditional Chinese medicine Chronic heart failure Data mining Network pharmacology BIOINFORMATICS Spleen Qi deficiency syndrome
暂未订购
Effect of Taoren Quyu Decoction on human endometrial cells and its anti-endometriosis activity in rats 被引量:6
2
作者 Hai-Zhi Liu Xiao-Xue Han +2 位作者 Jia Liu Feng-Cheng Zhu Rui-Man Li 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2017年第7期758-762,共5页
Objective: To study the effect of Taoren Quyu Decoction (TQD) on endometrial cells in patients with endometriosis (EMs) and EMs in rats. Methods: A total of 60 female Wistar rats were randomly divided into 4 groups, n... Objective: To study the effect of Taoren Quyu Decoction (TQD) on endometrial cells in patients with endometriosis (EMs) and EMs in rats. Methods: A total of 60 female Wistar rats were randomly divided into 4 groups, namely, normal group, model group, positive group and TQD group, each group having 15 rats. Except the normal group, EMs model was established in the other three groups by transplanting the rat autologous endometrium. After 4 weeks of intragastric administration, blood, eutopic and ectopic endometrial tissues of rats in each group were collected to detect the serum levels of estrogen (E2), cancer antigen 125 (CA125), endometrial antibody (EMA13), and expressions of microvessel density (MVD), vascular endothelial growth factor (VEGF) and angiopoietin (Ang-2). The volume of endometriosis cyst was determined simultaneously. For the in vitro culture of human endometrial cells, 4 groups, namely, normal group, model group, positive group and TQD group were used. The positive group and TQD group were treated with danazol and TQD respectively. Then 24 h after the treatment, the expressions of survivin and tumor suppressor gene (p53) of each group were detected. Results: The volumes of the endometriosis cysts in the positive group and the TQD group were significantly reduced compared with the model group (P<0.05). The serum levels of E2, CA125 and EMAb, and the expressions of MVD. VEGF and Ang-2 in the model group were significantly increased compared with the normal group (P<0.0.5): while they were all significantly reduced in the positive group and TQD group (P<0.05). Compared with the normal group, the expression of survivin in the model group was significantly up regulated (/1/40.05), and expression of p53 was significantly reduced (P<0.05); compared with the model group, the expressions of survivin in the positive and TQD groups were significantly decreased (P<0.05), and expression of p53 was significantly up-regulated (P<0.05). The difference between positive group and TQD group was not statistically significant (P>0.05). Conclusions: TQD has a significant anti-EMs effect, and its mechanism of action may be related to anti-angiogenesis and promoting apoptosis of ectopic endometrial cell. 展开更多
关键词 Taoren quyu Decoction ENDOMETRIOSIS Endometrial cell RATS ANGIOGENESIS Apoptosis
暂未订购
Yiqi Yangyin and Huatan Quyu granule can improve skeletal muscle energy metabolism in a type 2 diabetic rat model by promoting the AMPK/SIRT/PGC-1α signalling pathway
3
作者 Wei Huang Jinna Liu +3 位作者 Jing Zhao Bangzhong Wang Biyuan Liu Ming Xie 《Journal of Traditional Chinese Medical Sciences》 2018年第2期128-138,共11页
Objective:To investigate how Yiqi Yangyin and Huatan Quyu granule (YYHO) improves skeletal muscle insulin resistance in a type 2 diabetic rat model and to discover whether the molecular mechanism is related to the pro... Objective:To investigate how Yiqi Yangyin and Huatan Quyu granule (YYHO) improves skeletal muscle insulin resistance in a type 2 diabetic rat model and to discover whether the molecular mechanism is related to the promotion of the AMPK/SIRT/PGC-1α signalling pathway.Methods:Rats were randomly divided into 4 groups:the normal group,the model group,the YYHQ granule group,and the pioglitazone group.The type 2 diabetic rat model was established by feeding a high-fat diet for 5 weeks along with a single intraperitoneal injection of 30 mg/kg streptozotocin (STZ).After modelling successfully,the appropriate drug was intragastrically administered to diabetic rats for 2 weeks,once per day.The YYHQ granule group was given a dose of 4.8 g/kg body weight per day,the pioglitazone group was given a dose of 1.35 mg/kg body weight per day.The doses for both groups were equivalent to the clinical equivalent dose based on a previous study.Other groups were gavaged with the same amount of saline water.Body weight,food intake,water intake,urine volume and grip strength were recorded weekly.The fasting blood glucose(FBG) was determined weekly using blood glucose test strips.The related glucose and lipid metabolism indexes,e.g.,fasting insulin (Fins),glycated haemoglobin (GHb),HOMA-IR,ISI,triglycerides (TG),total cholesterol (TC),high-density lipoprotein cholesterol (HDL-C),low-density lipoprotein cholesterol (LDL-C) and free fatty acid (FFA),were determined using biochemical method.The mRNA expression levels of adenosine monophosphate-activated protein kinase (AMPK),peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α),carnitine palmitoyl transterase-1 (CPT-1),Sirtuin 1 (SIRT1),and Sirtuin 3 (SIRT3) were assessed using quantitative real-time PCR (qRT-PCR).The protein expression levels of creatine kinase (CK),Ca2+ ATPase,α-Actin,AMPK,PGC-1α and CPT-1 were determined using enzyme-linked immunosorbent assay method (ELISA).Results:Body weight decreased significantly (P <.01),food intake,water intake and urine volume increased significantly (P <.01),and grip strength decreased significantly (P <.01) in the model group compared with the normal group.The levels of FBG,Fins,GHb and HOMA-IR increased significantly (P <.01),and the ISI decreased significantly (P <.01) in the model group.The levels of TG,TC,LDL-C and FFA increased significantly (P <.05 or P <.01),and the level of HDL-C decreased significantly (P <.05) in the model group.These changes were reversed after treatment with YYHQ granule or pioglitazone.Compared with the model group,the YYHQ granule and pioglitazone groups significantly improve body weight,water intake and urine volume (P <.05 or P <.01),however,both treatments had no significant effect on food intake (P >.05).The levels of FBG,Fins,GHb,HOMA-IR and ISI were improved significantly (P <.01) and the levels of TG,TC and LDL-C were improved significantly (P <.05 or P <.01),however,both treatments had no significant effect on the levels of HDL-C and FFA (P >.05).Further results indicated that YYHQ granule significantly decreased the mRNA expression of AMPK,PGC-1α,CPT-1,SIRT1 and SIRT3 in skeletal muscle (P <.01) and the pioglitazone group showed similar effects;moreover,the protein expression levels of CK,Ca2+ATPase,α-Actin,AMPK,PGC-1α and CPT-1 in skeletal muscle significantly decreased (P <.01),however,pioglitazone had no significant effect on CK and α-Actin (P >.05).Conclusion:The possible molecular mechanism of YYHQ granule improving skeletal muscle insulin resistance in a type 2 diabetic rat model may be related to the stimulation of energy metabolism in skeletal muscle via the AMPK/SIRT/PGC-1α signalling pathway. 展开更多
关键词 TYPE 2 diabetes mellitus (T2DM) Yiqi Yangyin and Huatan quyu GRANULE (YYHQ) Skeletal muscle Energy metabolism AMPK/SIRT/PGC-1α signalling pathway
暂未订购
Effect of Huatan Quyu Decoction on Stable Angina Pectoris Patients with Coronary Heart Disease of Phlegm and Blood Stasis Syndrome
4
作者 GONG Weiling 《外文科技期刊数据库(文摘版)医药卫生》 2021年第5期395-396,共3页
Experimental objective: to study the effect of Huatan Quyu Decoction on patients with stable angina pectoris of coronary heart disease with phlegm-blood stasis syndrome. Step: select 100 patients from the patients rec... Experimental objective: to study the effect of Huatan Quyu Decoction on patients with stable angina pectoris of coronary heart disease with phlegm-blood stasis syndrome. Step: select 100 patients from the patients received by the hospital in the past two years, and then randomly divide them into 2 groups with 50 patients in each group. Use different treatment methods to compare and study the differences between the two. The patients in the first group were treated with conventional methods, mainly isosorbide dinitrate, while the patients in the second group were treated with Huatan Quyu Decoction. The experiment is mainly to analyze the differences of the related physical indexes between the two groups of patients before and after treatment, and the main parameters include: cardiac function, degree of angina pectoris. Experimental results: There was no significant difference in physical indexes between the two groups before treatment, while the physical condition of the second group improved after treatment, while the physical condition of the first group did not improve significantly. Conclusion: Huatan Quyu Decoction has certain effect in treating stable angina pectoris of coronary heart disease, and has good effect in improving cardiac function of patients, which can be used clinically. 展开更多
关键词 Huatan quyu Decoction patients with stable angina pectoris of coronary heart disease due to phlegm
暂未订购
祛瘀生肌方治疗慢性糖尿病性溃疡瘀证的临床研究
5
作者 李苏 郭婉军 +5 位作者 丁晓杰 陈佳乐 蒯仂 李欣 李福伦 迮侃 《中华中医药杂志》 北大核心 2025年第7期3941-3945,共5页
目的:明确祛瘀生肌方临床治疗慢性糖尿病性溃疡瘀证的有效性和安全性。方法:采用随机、对照研究方法,以慢性糖尿病性溃疡瘀证患者为研究对象,经4周祛瘀生肌方治疗后,比较治疗前后创面面积、愈合速度、症状积分、面积疗效、症状积分疗效... 目的:明确祛瘀生肌方临床治疗慢性糖尿病性溃疡瘀证的有效性和安全性。方法:采用随机、对照研究方法,以慢性糖尿病性溃疡瘀证患者为研究对象,经4周祛瘀生肌方治疗后,比较治疗前后创面面积、愈合速度、症状积分、面积疗效、症状积分疗效和安全性。结果:对照组创面面积疗效总有效率为40.00%(12/30),治疗组总有效率为80.65%(25/31),治疗组显著高于对照组(P<0.01)。结论:祛瘀生肌方能促进慢性糖尿病性溃疡瘀证患者创面愈合,改善创面症状积分。 展开更多
关键词 祛瘀生肌方 糖尿病 慢性糖尿病性溃疡 皮肤溃疡 瘀证 临床研究
原文传递
固本祛瘀解毒方治疗慢性阻塞性肺疾病合并阻塞性睡眠呼吸暂停低通气综合征夜间低氧血症的临床观察
6
作者 何沂 李紫雨 +3 位作者 张文江 高金柱 樊长征 王蓓蓓 《中国实验方剂学杂志》 北大核心 2025年第6期146-153,共8页
目的:观察固本祛瘀解毒方治疗慢性阻塞性肺疾病(COPD)合并阻塞性睡眠呼吸暂停低通气综合征(OSAHS)夜间低氧血症(肺脾肾虚、瘀毒交阻证)的临床疗效及安全性。方法:采用前瞻性、随机双盲、安慰剂对照的设计方法,选择符合COPD合并OSAHS的... 目的:观察固本祛瘀解毒方治疗慢性阻塞性肺疾病(COPD)合并阻塞性睡眠呼吸暂停低通气综合征(OSAHS)夜间低氧血症(肺脾肾虚、瘀毒交阻证)的临床疗效及安全性。方法:采用前瞻性、随机双盲、安慰剂对照的设计方法,选择符合COPD合并OSAHS的西医诊断标准且中医辨证为肺脾肾虚、瘀毒交阻证患者96例,随机分为观察组和对照组,各48例。两组均在西医常规治疗基础上,观察组加用固本祛瘀解毒方,对照组加用中药安慰剂治疗,疗程均为90 d。比较治疗前后两组患者夜间最低血氧饱和度(SpO_(2))、呼吸暂停指数(AHI)、OSAHS疗效判定、中医证候疗效评定、中医症状积分的变化。结果:观察组脱落5例、对照组脱落8例,实际完成观察组43例,对照组40例。与治疗前比较,观察组夜间最低SpO_(2)、AHI均显著改善(P<0.01),且显著优于对照组(P<0.01);OSAHS疗效观察组优于对照组(χ^(2)=7.085,P<0.05);中医证候疗效,观察组总有效率81.40%(35/43),对照组总有效率15.00%(6/40),观察组明显高于对照组(χ^(2)=36.78,P<0.01);中医症状积分二组均较治疗前改善,在打鼾、憋醒、嗜睡、咳嗽4项主证上疗效相当,但在头昏头痛、胸闷胸痛、喘息、口干口渴等10项细节上观察组优于对照组(P<0.05)。结论:固本祛瘀解毒方联合常规西医治疗COPD合并OSAHS夜间低氧血症(肺脾肾虚、瘀毒交阻证),可改善患者最低SPO_(2)、提升OSAHS控制水平、提高生活质量、改善临床症状。 展开更多
关键词 慢性阻塞性肺疾病 阻塞性睡眠呼吸暂停低通气综合征 低氧血症 固本祛瘀解毒方 随机双盲 临床观察
原文传递
益气养阴祛瘀汤治疗干燥综合征对患者腮腺核素动态显像指标、免疫功能的影响研究
7
作者 徐杨杨 谢海 刘元奎 《中华中医药学刊》 北大核心 2025年第6期130-133,共4页
目的研究益气养阴祛瘀汤治疗干燥综合征对患者腮腺核素动态显像指标、免疫功能的影响。方法选取2022年1月—2023年1月医院治疗的干燥综合征患者84例,根据随机数表法随机均分为两组,观察组、对照组各42例。对照组患者采用常规西药治疗,... 目的研究益气养阴祛瘀汤治疗干燥综合征对患者腮腺核素动态显像指标、免疫功能的影响。方法选取2022年1月—2023年1月医院治疗的干燥综合征患者84例,根据随机数表法随机均分为两组,观察组、对照组各42例。对照组患者采用常规西药治疗,观察组在对照组基础上采用益气养阴祛瘀汤治疗,两组用药疗程3个月。比较两组的中医症状量化评分,疾病活动度改变[干燥综合征疾病活动指数(European League Against Rheumatism SS disease activity index,ESSDAI)和EULAR干燥综合征患者报告指数(EULAR SS Patient Reported Index,ESSPRI)],腮腺核素动态显像指标[摄取分数(intake fraction,IF)、排泌分数(excretion fraction,EF)],免疫功能指标[血沉(erythrocyte sedimentation Rate,ESR)、C反应蛋白(C-reactive protein,CRP)、免疫球蛋白G(immunoglobulin G,IgG)、抗干燥综合征抗原A(Sj9gren's syndrome type A,SSA)抗体、抗干燥综合征抗原B(Sj9gren's syndrome type B,SSB)抗体]及不良反应发生情况。结果治疗前,两组患者的各项观察指标差异无统计学意义(P>0.05)。治疗后,观察组中医症状舌红津少、无苔/少苔/花剥、口干欲饮、眼干少泪评分均显著低于对照组[(1.72±0.53)(1.96±0.70)(2.03±0.91)(1.70±0.84)分vs(1.98±0.61)(2.36±0.59)(2.89±0.72)(2.13±0.77)分](P<0.05),观察组ESSDAI、EULAR评分均显著高于对照组[(5.92±1.60)(4.36±1.02)分vs(6.87±1.54)(5.39±0.96)分](P<0.05),腮腺核素动态显像IF、EF均显著高于对照组[(1.87±0.26)%、(21.07±4.20)%vs(1.74±0.19)%、(17.96±3.75)%],免疫功能指标ESR、IgG、抗SSA抗体阳性率、抗SSB抗体阳性率均显著优于对照组[(19.83±1.84)mm/h、(6.90±1.37)g/L、(41.28±5.69)%、(28.91±4.03)%vs(21.05±1.69)mm/h、(8.81±1.19)g/L、(53.47±5.18)%、(36.28±3.71)%](P<0.05)。观察组不良反应发生率7.14%与对照组11.90%比较,差异无统计学意义(P>0.05)。结论益气养阴祛瘀汤治疗干燥综合征效果满意,其能够更有效地缓解患者症状,改善机体免疫功能和腮腺核素动态显像指标,且用药安全性可靠,具有应用价值。 展开更多
关键词 干燥综合征 益气养阴祛瘀汤 硫酸羟氯喹片 腮腺核素动态显像 免疫功能
原文传递
子午流注针法联合补气祛瘀汤治疗卒中后环咽肌失弛型吞咽障碍临床研究
8
作者 吴梦婷 刘薇 《中华中医药学刊》 北大核心 2025年第5期214-217,共4页
目的探究子午流注针法联合补气祛瘀汤在卒中后环咽肌失弛型吞咽障碍治疗中的临床作用。方法收集卒中后环咽肌失弛型吞咽障碍患者60例,随机分为两组,试验组和对照组各30例。两组接受基础疗法,对照组予以补气祛瘀汤,试验组在对照组的基础... 目的探究子午流注针法联合补气祛瘀汤在卒中后环咽肌失弛型吞咽障碍治疗中的临床作用。方法收集卒中后环咽肌失弛型吞咽障碍患者60例,随机分为两组,试验组和对照组各30例。两组接受基础疗法,对照组予以补气祛瘀汤,试验组在对照组的基础上予以子午流注针法。对比两组颏下肌群表面肌电变化、洼田俊夫饮水试验(water swallow test,WST)、标准吞咽功能评估量表(standardized swallowing assessment,SSA)、吞咽障碍特异性生活质量量表(swallow quality-of-life questionnaire,SWAL-QOL)、吞咽X线荧光透视造影检查(videofluoroscopic swallowing study,VFSS)、临床疗效及并发症总发生率。结果治疗后两组下颏下肌群肌电均方根值(root mean square,RMS)水平降低(P<0.05);与对照组相比,试验组下颏下肌群RMS水平较低(P<0.05)。治疗后两组患者WST检查情况降低,且试验组WST检查低于对照组(P<0.05)。治疗后,两组SSA评分降低,SWAL-QOL评分、VFSS评分升高,且试验组SSA评分更低,SWAL-QOL、VFSS评分更高(P<0.05)。疗后试验组临床总有效率高于对照组,发生率低于对照组(P<0.05)。结论给予卒中后环咽肌失弛型吞咽障碍患者补气祛瘀汤联合子午流注针法的治疗措施,疗效佳,具有改善吞咽功能的优势,安全性高。 展开更多
关键词 补气祛瘀汤 子午流注针法 卒中后环咽肌失弛型吞咽障碍
原文传递
健脾益肾化痰祛瘀方联合间歇性禁食疗法治疗单纯性肥胖的效果
9
作者 金斌斌 管子函 +2 位作者 戴盛锋 谢帆 张特 《江苏医药》 2025年第6期607-610,615,共5页
目的观察健脾益肾化痰祛瘀方联合间歇性禁食疗法治疗单纯性肥胖的临床效果。方法72例单纯性肥胖患者随机分为研究组和对照组,每组36例。对照组接受常规治疗联合间歇性禁食疗法;研究组在对照组基础上加用健脾益肾化痰祛瘀方治疗,连续治疗... 目的观察健脾益肾化痰祛瘀方联合间歇性禁食疗法治疗单纯性肥胖的临床效果。方法72例单纯性肥胖患者随机分为研究组和对照组,每组36例。对照组接受常规治疗联合间歇性禁食疗法;研究组在对照组基础上加用健脾益肾化痰祛瘀方治疗,连续治疗3个月。比较两组患者糖脂代谢指标和体质指标的变化。结果治疗前两组糖脂代谢指标比较均无统计学差异(P>0.05)。治疗后,两组FBG、餐后2-h血糖、HbA1c、HOMA-IR、TG、TC和LDL-C水平均较治疗前降低,HDL-C水平较治疗前升高(P<0.01),且研究组变化更为明显(P<0.01)。治疗后,研究组体重、腰围、臀围及BMI下降幅度均大于对照组(P<0.05),腰臀比小于对照组(P<0.05)。结论健脾益肾化痰祛瘀方联合间歇性禁食疗法治疗单纯性肥胖效果良好,可加快减重速度,调控糖脂代谢。 展开更多
关键词 单纯性肥胖 健脾益肾化痰祛瘀方 间歇性禁食疗法 糖脂代谢
原文传递
祛瘀消肿方外敷配合手法整复夹板外固定治疗老年桡骨远端C型骨折的临床研究 被引量:1
10
作者 周承亮 张伟刚 +2 位作者 蒋铭 陆云 张强 《中国医学创新》 2025年第10期92-97,共6页
目的:回顾性分析祛瘀消肿方外敷配合手法整复夹板外固定治疗老年桡骨远端C型骨折的临床效果。方法:选取2022年1月—2023年1月昆山市中医医院就诊的120例老年桡骨远端C型骨折患者,按照AO分类法中C1、C2、C3型分为A组、B组、C组。三组均... 目的:回顾性分析祛瘀消肿方外敷配合手法整复夹板外固定治疗老年桡骨远端C型骨折的临床效果。方法:选取2022年1月—2023年1月昆山市中医医院就诊的120例老年桡骨远端C型骨折患者,按照AO分类法中C1、C2、C3型分为A组、B组、C组。三组均接受昆山中医院闵氏伤科正骨手法整复后夹板外固定,同时配合祛瘀消肿方外敷,统计分析三组患者的视觉模拟评分法(VAS)评分、掌倾角、尺偏角及桡骨高度。末次随访采用腕关节Gartland-Werley评分进行腕关节功能评价,观察并统计患者治疗期间出现的并发症。结果:手法整复后即刻、治疗2周、1个月、3个月复查三组掌倾角、尺偏角及桡骨高度均比治疗前改善;其中整复后三组即刻复查影像学指标差异均无统计学意义(P>0.05);三组患者治疗前VAS评分差异有统计学意义(P<0.05),但三组经治疗第3、7、14天的VAS评分差异均无统计学意义(P>0.05);治疗3个月A组影像学指标明显优于B组、C组,差异均有统计学意义(P<0.05);末次随访Gartland-Werley腕关节功能评分,A组临床疗效优良率为86.84%,高于B组的69.05%及C组的62.50%,差异均有统计学意义(P<0.05)。结论:祛瘀消肿方配合手法整复夹板外固定治疗老年桡骨远端C型骨折对患者早期复位后疼痛具有一定的治疗效果;该法对于桡骨远端骨折C1型患者,腕关节功能恢复优良率达86.84%,对于C2、C3型骨折也可获得较好的效果,可以作为不耐受手术或功能要求不是很高的老年患者的一种选择。 展开更多
关键词 闵氏伤科手法 夹板外固定 祛瘀消肿方 老年桡骨远端C型骨折
暂未订购
补肾柔肝祛瘀汤联合电针对薄型子宫内膜患者子宫内膜血流阻力指数、内分泌指标的影响研究 被引量:1
11
作者 贾红伟 白杰 赵彦 《中国医院用药评价与分析》 2025年第4期412-415,共4页
目的:探讨补肾柔肝祛瘀汤联合电针对薄型子宫内膜患者的治疗效果。方法:采用前瞻性研究方法,选取2023年1月至2024年4月该院门诊收治的薄型子宫内膜患者90例,以随机数字表法分为A组(常规西药治疗)、B组(补肾柔肝祛瘀汤)和C组(补肾柔肝祛... 目的:探讨补肾柔肝祛瘀汤联合电针对薄型子宫内膜患者的治疗效果。方法:采用前瞻性研究方法,选取2023年1月至2024年4月该院门诊收治的薄型子宫内膜患者90例,以随机数字表法分为A组(常规西药治疗)、B组(补肾柔肝祛瘀汤)和C组(补肾柔肝祛瘀汤+电针),每组30例。观察患者治疗前后子宫内膜厚度、子宫内膜动脉血流阻力指数和内分泌指标变化情况,同时统计患者妊娠率、不良反应发生率。结果:治疗后,三组患者的子宫内膜厚度均大于治疗前,差异均有统计学意义(P<0.05);B组患者与A、C组比较,差异有统计学意义(P<0.05);A、C组患者组间比较,差异无统计学意义(P>0.05)。治疗后,三组患者的雌二醇、孕酮水平高于治疗前,差异均有统计学意义(P<0.05),而三组患者间比较则差异无统计学意义(P>0.05)。治疗后,三组患者的子宫内膜动脉血流搏动指数(PI)、阻力指数(RI)低于治疗前,A、C组患者的PI、RI低于B组,差异均有统计学意义(P<0.05);A、C组患者的PI、RI比较,差异无统计学意义(P>0.05)。治疗后,A、B和C组患者的妊娠率分别为30.00%(9/30)、16.67%(5/30)和46.67%(14/30);B组患者明显低于A、C组,差异有统计学意义(P<0.05);C组患者稍高于A组,但差异无统计学意义(P>0.05)。B、C组患者的不良反应发生率分别为3.33%(1/30)、3.33%(1/30),低于A组的20.00%(6/30),差异均有统计学意义(P<0.05)。结论:采用补肾柔肝祛瘀汤联合电针治疗薄型子宫内膜,有助于增加患者子宫内膜厚度、调节内分泌水平,同时进一步改善子宫内膜血供,促进妊娠,且更安全、有效。 展开更多
关键词 薄型子宫内膜 补肾柔肝祛瘀汤 电针 子宫内膜厚度 血流阻力指数 内分泌指标
暂未订购
祛瘀消肿汤对老年股骨粗隆间骨折术后患者的治疗效果 被引量:3
12
作者 刘晓军 常峰 《中国药物与临床》 2025年第2期78-82,共5页
目的探讨祛瘀消肿汤对老年股骨粗隆间骨折术后患者的疗效。方法回顾性分析2018年2月至2023年6月在石楼县医疗集团人民医院进行治疗的80例骨折患者的临床资料,依据治疗方法分为对照组(40例)和观察组(40例)。对照组术后行常规抗凝疗法,观... 目的探讨祛瘀消肿汤对老年股骨粗隆间骨折术后患者的疗效。方法回顾性分析2018年2月至2023年6月在石楼县医疗集团人民医院进行治疗的80例骨折患者的临床资料,依据治疗方法分为对照组(40例)和观察组(40例)。对照组术后行常规抗凝疗法,观察组在常规抗凝疗法基础上联合祛瘀消肿汤治疗,对比2组不同的治疗效果(中医证候积分、下肢深静脉血栓情况、睡眠质量、临床指标、治疗有效率)。结果治疗后观察组得分低于同组治疗前及治疗后的对照组,差异有统计学意义(P<0.05);观察组下肢深静脉血栓率比对照组低,差异有统计学意义(P<0.05);治疗后观察组得分低于同组治疗前及治疗后的对照组,差异有统计学意义(P<0.05);观察组临床指标(初次下床时间与住院时间)均短于对照组,差异有统计学意义(P<0.05);观察组治疗有效率比对照组高,差异有统计学的意义(P<0.05);术后1~3 d患者疼痛评分均降低,且观察组评分低于对照组,差异有统计学意义(P<0.05);干预前,2组间的髋关节Harris得分相近(P>0.05);干预后,观察组该项得分高于对照组(P<0.05);观察组感染、血栓形成、骨不愈合的发生率(5.0%)低于对照组(17.5%),差异有统计学意义(P<0.05)。结论对老年股骨粗隆间骨折患者术后采用祛瘀消肿汤治疗,可以很好地改善其临床症状,预防静脉血栓的同时还能改善睡眠质量,治疗效果好,安全可靠,建议临床推荐使用。 展开更多
关键词 股骨骨折 静脉血栓 睡眠质量 祛瘀消肿汤
暂未订购
解毒祛瘀滋阴方抑制M1/M2型巨噬细胞极化改善降植烷诱导的狼疮样改变
13
作者 甘逸鸿 林可 +9 位作者 周诗慧 金萌 陈胜钰 章伊琳 刘景群 包洁 黄硕 谢冠群 徐莉 范永升 《中华中医药杂志》 北大核心 2025年第5期2245-2250,共6页
目的:从M1/M2巨噬细胞极化探讨解毒祛瘀滋阴方改善降植烷诱导的系统性红斑狼疮(SLE)小鼠多器官损伤的作用机制。方法:将30只BALB/c小鼠分为对照组(腹腔注射PBS,n=6)和SLE模型组(腹腔注射降植烷,n=24)。造模成功后,随机分为SLE组、解毒... 目的:从M1/M2巨噬细胞极化探讨解毒祛瘀滋阴方改善降植烷诱导的系统性红斑狼疮(SLE)小鼠多器官损伤的作用机制。方法:将30只BALB/c小鼠分为对照组(腹腔注射PBS,n=6)和SLE模型组(腹腔注射降植烷,n=24)。造模成功后,随机分为SLE组、解毒祛瘀滋阴方组(36 g/kg)、激素组(强的松,5 mg/kg)及解毒祛瘀滋阴方联合激素组,每组6只。连续干预8周。通过流式细胞术检测脾脏、肾脏、关节M1/M2巨噬细胞比例;生化分析评估肾功能(肌酐、尿素氮);HE染色观察肾脏病理;行为学实验(强迫游泳、悬尾、旷场)评价神经精神症状;结合网络药理学解析潜在作用靶点。结果:与SLE组比较,解毒祛瘀滋阴方组及解毒祛瘀滋阴方联合激素组显著降低脾脏、肾脏、关节M1/M2比例(P<0.01),显著改善肾功能指标(肌酐、尿素氮)(P<0.05,P<0.01)及焦虑/抑郁样行为(静止时间减少、运动距离增加)(P<0.01,P<0.05)。网络药理学筛选出405个共同靶点,其中槲皮素可能通过调控CASP8、MMP9等靶点干预巨噬细胞分化。结论:解毒祛瘀滋阴方通过抑制M1/M2巨噬细胞极化减轻SLE多器官损伤,其机制可能与调控巨噬细胞分化相关通路有关。联合激素治疗也有效改善病情,为临床“增效减毒”策略提供实验依据。 展开更多
关键词 解毒祛瘀滋阴方 系统性红斑狼疮 巨噬细胞极化 降植烷 机制
原文传递
基于控糖效果及胰岛素抵抗变化情况探究化浊疏肝祛瘀法联合穴位贴敷在2型糖尿病前期患者中的应用价值 被引量:4
14
作者 游京园 刘文丽 +2 位作者 吕铭菲 高慧峰 沈华 《辽宁中医药大学学报》 CAS 2025年第1期186-190,共5页
目的基于控糖效果及胰岛素抵抗变化情况探究化浊疏肝祛瘀法联合穴位贴敷在2型糖尿病前期(T2DM)患者中的应用价值。方法选择张家口市中医院2021年5月—2023年5月收治的118例2型糖尿病前期患者。按随机数字表法分为对照组与观察组各59例,... 目的基于控糖效果及胰岛素抵抗变化情况探究化浊疏肝祛瘀法联合穴位贴敷在2型糖尿病前期(T2DM)患者中的应用价值。方法选择张家口市中医院2021年5月—2023年5月收治的118例2型糖尿病前期患者。按随机数字表法分为对照组与观察组各59例,对照组给予生活方式干预,观察组给予生活方式干预+化浊疏肝祛瘀汤+穴位贴敷治疗。对比两组疗效、中医证候积分、控糖效果、胰岛素抵抗变化情况。结果干预后,观察组的疗效等级及有效率均优于对照组(P<0.05);两组各主次证候积分均较降低(P<0.05),且观察组的倦怠乏力、纳呆便溏、头身困重、脘腹胀满、口淡无味或黏腻的积分均低于对照组(P<0.05);两组空腹血糖(FPG)、餐后2 h血糖(2 h PG)、血红蛋白(HbAlc)降低(P<0.05),且观察组均低于对照组(P<0.05);两组胰岛素抵抗指数(HOMA-IR)均降低、胰岛β细胞功能指数(HOMA-β)均升高(P<0.05),且观察组的HOMA-IR低于对照组、HOMA-β高于对照组(P<0.05)。干预期间,观察组患者未出现肝肾降低情况及不良反应。结论化浊疏肝祛瘀汤联合中药贴敷治疗糖尿病前期疗效确切,可明显改善患者症状,降低血糖及胰岛素抵抗,改善胰岛β细胞功能,且安全性较好。 展开更多
关键词 2型糖尿病前期 控糖效果 胰岛素抵抗 化浊疏肝祛瘀法 穴位贴敷
原文传递
补肾化痰祛瘀方改善高脂饮食联合来曲唑诱导肥胖型PCOS小鼠胰岛素抵抗与骨骼肌功能
15
作者 杜尘 王拥军 +5 位作者 杜平 赫明超 张起越 傅晓丹 郭怡洵 张岩 《中国骨质疏松杂志》 北大核心 2025年第10期1422-1427,1458,共7页
目的研究补肾化痰祛瘀方改善肥胖型多囊卵巢综合征(polycystic ovary syndrome,PCOS)小鼠骨骼肌生物学功能的效应与潜在机制。方法50只雌性2月龄小鼠随机分组,PCOS组小鼠于背部皮下植入来曲唑缓释片,对照组(Con)小鼠植入空载缓释片。各... 目的研究补肾化痰祛瘀方改善肥胖型多囊卵巢综合征(polycystic ovary syndrome,PCOS)小鼠骨骼肌生物学功能的效应与潜在机制。方法50只雌性2月龄小鼠随机分组,PCOS组小鼠于背部皮下植入来曲唑缓释片,对照组(Con)小鼠植入空载缓释片。各组小鼠均给予高脂饲料饲养5周,同时给予低、高剂量补肾化痰祛瘀方干预5周。实验结束后,检测空腹血糖、口服糖耐量试验(OGTT)等;评价卵巢、骨骼肌组织学病理;测量抓力、骨骼肌湿重系数;测定小鼠血清硫酸脱氢表雄酮DHEAS及胰岛素含量。结果与Con组相比,PCOS组小鼠体质量(P<0.01)、空腹血糖(P<0.05)、血清胰岛素水平(P<0.05)均显著性增高,OGTT后血糖显著升高(P<0.01),卵巢发生囊性扩张等典型改变。补肾化痰祛瘀方干预后,空腹血糖、OGTT后血糖水平以及血清胰岛素均显著下降,卵巢无明显闭锁囊性卵泡,小鼠抓力、骨骼肌湿重系数、骨骼肌肌纤维面积增加,骨骼肌组织AKT(Ser473)位点磷酸化水平显著性上调。结论补肾化痰祛瘀方能够改善肥胖型PCOS小鼠胰岛素抵抗与骨骼肌功能,提示其对于临床PCOS患者可能有额外的骨骼肌获益。 展开更多
关键词 多囊卵巢综合征 补肾化痰祛瘀方 骨骼肌 胰岛素抵抗 AKT
暂未订购
Expressions of VEGF and Ki-67 in Eutopic Endometrium of Patients with Endometriosis and Effect of Quyu Jiedu Recipe (祛瘀解毒方) on VEGF Expression 被引量:4
16
作者 连方 刘海萍 +6 位作者 王云霞 张建伟 孙振高 马凤梅 张宁 刘延荷 孟茜 《Chinese Journal of Integrative Medicine》 SCIE CAS 2007年第2期109-114,共6页
Objective: To observe the clinical efficacy of Quyu Jiedu Recipe (祛瘀解毒方,QJR) in treating endometriosis (EM), and to explore the levels of vascular endothelial growth factor (VEGF) and cell proliferative nu... Objective: To observe the clinical efficacy of Quyu Jiedu Recipe (祛瘀解毒方,QJR) in treating endometriosis (EM), and to explore the levels of vascular endothelial growth factor (VEGF) and cell proliferative nucleoprotein antigen (Ki-67), their changes before and after treatment and the clinical significance in the trial. Methods: Fifty patients of EM were randomly assigned to two groups. The 26 patients in the Q JR group were treated with Q JR, and the 24 patients in the gestrinone (GT) group with gestrinone. Besides, a normal control group with 20 healthy women was set up. The therapeutic effects in the two treated groups were compared. Expressions of VEGF and Ki-67 in eutopic endometrium of all subjects (with both patients and healthy women at the median secretive phase) were determined with immunohistochemical stain before treatment, and the determination in the two treated groups was repeated after 3-month treatment in the same phase. Results: Before treatment, the VEGF and Ki-67 expression positive rates and their mean optic density (MOD) were higher in patients than in healthy women (P〈0.05). After treatment, the positive rate and MOD of VEGF expression lowered significantly than before treatment (P〈0.05), but those of Ki-67 changed insignificantly, and comparison between the two treated groups showed no significant difference (P〉0.05). Conclusion: Q JR could markedly improve the symptoms of menorrhagia and menstrual disorder, and its mechanism might be related with the lowering of eutopic endometrial VEGF expression. VEGF and Ki-67 show a high expression in eutopic endometrium of patients with EM. 展开更多
关键词 ENDOMETRIOSIS quyu Jiedu Recipe stagnancy of toxin vascular endothelial growth factor KI-67
原文传递
Effect of Quyu Jiedu Granule(祛瘀解毒颗粒) on Micro-environment of Ova in Patients with Endometriosis 被引量:3
17
作者 连方 李新玲 +3 位作者 孙振高 张建伟 刘延荷 马凤梅 《Chinese Journal of Integrative Medicine》 SCIE CAS 2009年第1期42-46,共5页
Objective:To observe the effect of Quyu Jiedu Granules(祛瘀解毒颗料,QJG) on the micro-environment of ova in patients with endometriosis(EM).Methods:Twenty EM patients who received in vitro fertilization and embryo tra... Objective:To observe the effect of Quyu Jiedu Granules(祛瘀解毒颗料,QJG) on the micro-environment of ova in patients with endometriosis(EM).Methods:Twenty EM patients who received in vitro fertilization and embryo transfer(IVF-ET) were randomized equally into a treated group and a control group. Further,20 patients who received IVF-ET due to oviduct factors were enrolled into a non-endometriosis group. The dosage of gonadotrophic hormone used,the number of ova attained,fertilization rate and clinical pregnancy ra... 展开更多
关键词 ENDOMETRIOSIS quyu Jiedu Granule in vitro fertilization follicular fluid granular cells tumor necrosis factorα interleukin 6
原文传递
Qingre Quyu Granule(清热祛瘀颗粒)Stabilizes Plaques through Inhibiting the Expression of Tenascin-C in Patients with Severe Carotid Stenosis 被引量:2
18
作者 王一 程文立 +6 位作者 王勇 彭婧嫔 袁杰 陈莉 潘琳 李鸿 郭健 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2015年第5期339-345,共7页
Objective: To investigate the therapeutic effects of Qingre Quyu Granule (请热祛瘀颗粒, QQG) on the patients with severe carotid stenosis, and to explore the mechanism of it. Methods: Ninety-six patients with seve... Objective: To investigate the therapeutic effects of Qingre Quyu Granule (请热祛瘀颗粒, QQG) on the patients with severe carotid stenosis, and to explore the mechanism of it. Methods: Ninety-six patients with severe carotid stenosis were enrolled in the study and were classified into a QQG group (n=48) and a control group (n=48) randomly using consecutively numbered envelopes. The patients in the QQG group were given QQG and Western medicine, those in the control group were given Western medicine merely, the course of treatment was 16 weeks. All patients went through endarterectomy after treatment. Plaques were subjected to the analysis of CD3, CD68, soluble intercellular adhesion molecule 1 (ICAM-1), matrix metalloprotease-9 (MMP-9), CD40L, tenascin-C, and collagen content lipid content by immunohistochemistry or polarized light analysis. Results: By the end of experiment, the expressions of CD3, CD68, ICAM-1, MMP9, CD40L and tenascin-C on the plaques were statistically significant lower in the QQG group compared with the control group (P〈0.01), The lipid content of the plaque was also significantly lower in the QQG group compared with the control group (P〈O.01), The interstitial collagen in the tissue sections of the plaques was also significantly higher in the QQG group in comparison with the control group (P〈0.01). Conclusion: QQG could stabilize carotid artery plaques through inhibiting pro-inflammation factors and restraining the tenascin-C and MMP9 pathway. 展开更多
关键词 vulnerable atherosclerotic plaque CD40L matrix metalloprotease-9 TENASCIN-C Chinesemedicine Qingre quyue Granule
原文传递
基于能量代谢重编程探讨“去宛陈莝”法治疗糖尿病肾病的机理
19
作者 金鑫艳 于珊珊 +3 位作者 徐媛颖 沙雯君 鲁郡 雷涛 《辽宁中医杂志》 北大核心 2025年第12期8-11,共4页
糖尿病肾病的发病机制是多因素的,越来越多的证据表明代谢异常引发的各种细胞应激反应加速糖尿病肾病的发展进程。能量代谢重编程以能量流向紊乱、代谢过程转变、系统功能障碍为特点,贯穿于糖尿病肾病的发生发展过程,其引发的氧化应激... 糖尿病肾病的发病机制是多因素的,越来越多的证据表明代谢异常引发的各种细胞应激反应加速糖尿病肾病的发展进程。能量代谢重编程以能量流向紊乱、代谢过程转变、系统功能障碍为特点,贯穿于糖尿病肾病的发生发展过程,其引发的氧化应激、脂质积累和葡萄糖代谢终产物增多等与中医理论糖尿病肾病之脏腑气化失司,浊瘀内生的病机本质趋同且表征相仿。对于此病的治疗当以“通”为用,故以《黄帝内经》所提出的“去宛陈莝”法作为治疗原则,袪浊邪,助气化,畅气机,推陈致新,使稳态恢复,神机气立,机体各个环节得以正常发挥其功能,以拮抗糖尿病肾病的进展。 展开更多
关键词 能量代谢重编程 气化 去宛陈莝 糖尿病肾病
原文传递
阿司匹林联合活血祛瘀方治疗下肢动脉硬化闭塞症的临床评价
20
作者 尹凌峰 曹烨民 +2 位作者 徐磊 倪皓轩 王御震 《中国药学杂志》 北大核心 2025年第5期539-546,共8页
目的 探讨阿司匹林联合活血祛瘀方治疗下肢动脉硬化闭塞症(ASO)的临床疗效。方法 选择本院收治的下肢ASO患者136例作为研究对象,年龄范围为49~87岁,平均年龄(65.00±6.54)岁。根据不同治疗方法分为2组,常规阿司匹林治疗68例纳入对照... 目的 探讨阿司匹林联合活血祛瘀方治疗下肢动脉硬化闭塞症(ASO)的临床疗效。方法 选择本院收治的下肢ASO患者136例作为研究对象,年龄范围为49~87岁,平均年龄(65.00±6.54)岁。根据不同治疗方法分为2组,常规阿司匹林治疗68例纳入对照组,活血祛瘀方联合阿司匹林治疗68例纳入研究组。比较两组患者治疗前后血小板功能、血流动力学指标、血脂指标、动脉硬化指标、健康状况(SF-36)及临床疗效。采用广义估计方程(GEE)模型分析下肢ASO临床疗效的影响因素以及踝肱指数(ankle-brachial index, ABI)在不同时点、不同组别和不同分期的交互效应。结果 2组患者接受治疗6周后各项血小板功能、血流动力学指标、血脂指标及动脉硬化指标与治疗前相比均具有显著差异(P<0.05),研究组患者血小板聚集率(platelet aggregation rate, PAR)、D二聚体(D-dimer, D-D)、纤维蛋白原(fibrinogen, FIB)、全血高切黏度(high whole blood viscosity, HWBV)、全血低切黏度(low whole blood viscosity, LWBV)、红细胞沉降率(erythrocyte sedimentation rate, ESR)、总胆固醇(total cholesterol, TC)、三酰甘油(triacylglycerol, TG)及低密度脂蛋白胆固醇(low density lipoprotein cholesterol, LDL-C)水平均显著低于对照组(P<0.05),而患者出血时间(bleeding time, BT)、高密度脂蛋白(high density lipoprotein cholesterol, HDL-C)、ABI、趾肱指数(toe-brachial index, TBI)、跛行距离、健康状况评分及临床疗效均显著高于对照组(P<0.05);GEE模型分析结果显示治疗方法、治疗时间及Fontaine分期均显著影响下肢ASO的临床疗效(P<0.05);交互效应分析中治疗2周、4周,研究组和对照组中Ⅲ期、Ⅳ期ASO患者ABI值差异显著(P<0.05),治疗6周时,不同治疗方式对Ⅱ期、Ⅲ期、Ⅳ期ASO患者ABI值的影响具有统计学意义(P<0.05)。结论 阿司匹林联合活血祛瘀方治疗下肢ASO在血小板功能、血流动力学、血脂及动脉硬化等指标的改善方面优于单独使用阿司匹林,且治疗6周后联合用药的研究组的治疗总有效率和健康状况SF-36评分显著高于对照组;治疗方法、治疗时间及Fontaine分期均显著影响下肢ASO的治疗效果。 展开更多
关键词 下肢动脉硬化闭塞症 活血祛瘀方 阿司匹林 临床疗效
原文传递
上一页 1 2 45 下一页 到第
使用帮助 返回顶部